Sunday 11 October 2026 Export all BMY data to Excel Powerpack

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.12 0.46 −0.77%

Follow BMY

Alert me

Market cap: $121.7B
P/E: 13.0×
Fwd P/E: 11.2×
Dividend yield: 4.26%
F-score: 8/9
Altman Z: 2.14
Beneish M: −2.69
Dividend safety: 63/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	15.19	15.59	17.04	12.69
P/S ratio Full definition →		1.91	2.28	2.55	2.39
P/FCF ratio Full definition →		6.00	8.54	10.38	10.29
P/Operating CF Full definition →		14.55	55.58	111.96	34.68
P/B ratio Full definition →		4.94	5.93	6.15	5.27
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		2.59	2.99	3.25	3.04
EV/EBITDA Full definition →		9.60	10.81	11.95	9.92
EV/Operating CF Full definition →		7.48	10.18	11.84	11.71
EV/FCF Full definition →		8.12	11.22	13.23	13.09
Quick Ratio Full definition →		0.99	0.94	1.04	1.16
Current Ratio Full definition →		1.27	1.26	1.42	1.53
Net Debt/EBITDA Full definition →		7.87	14.06	8.86	6.85
Debt/Assets Full definition →		50.55%	50.10%	51.41%	49.20%
Debt/Equity Full definition →		2.63	2.44	2.21	1.93
Asset Turnover Full definition →		0.50	0.53	0.54	0.54
Operating CF/Net income Full definition →		2.87	1.82	0.41	1.02
Capex/Depreciation Full definition →		(0.32)	(0.38)	(0.58)	(0.51)
Research and Development Expense of Revenue Full definition →		20.68%	20.68%	23.06%	22.81%
Selling, General and Administrative Expense of Revenue Full definition →		14.64%	17.45%	14.07%	14.08%
Intangible Assets out of Total Assets Full definition →		0.44	0.45	0.46	0.45
Share Based Compensation of Revenue Full definition →		1.14%	1.06%	1.27%	1.04%
Graham Net Nets Full definition →		(0.46)	(0.38)	(0.32)	(0.31)
Graham Number Full definition →		24.71	26.61	28.11	33.41
Earnings Yield Full definition →		6.59%	6.41%	5.87%	7.88%
Free Cash Flow Yield Full definition →		16.66%	11.71%	9.63%	9.72%
Revenue per Share Full definition →		6.00	6.15	5.64	6.35
Operating CF per Share Full definition →		3.10	0.97	0.54	1.66
Capex per Share Full definition →		(0.16)	(0.18)	(0.17)	(0.15)
Free Cash Flow per Share Full definition →		2.94	0.79	0.37	1.51
Cash per Share Full definition →		8.11	5.25	5.15	5.42
Shareholders Equity per Share Full definition →		9.14	9.10	9.86	10.93
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		9.14	9.10	9.86	10.93
Free Cash Flow Full definition →		5,991.00	1,604.00	757.00	3,088.00
Working Capital Full definition →		7,494.00	5,973.00	8,050.00	9,920.00
Capital Expenditures Full definition →		(320.00)	(370.00)	(347.00)	(305.00)
Net Current Asset Value Full definition →		(42,659.00)	(42,143.00)	(39,166.00)	(36,736.00)
EV/EBIT Full definition →		15.48	15.45	16.42	12.57
Capex to Sales Full definition →		0.03	0.03	0.03	0.02
Price to Operating Income Full definition →		11.43	11.76	12.88	9.88
Other line items
Average Receivables Full definition →		11,224.00	11,080.50	10,084.50	10,984.00
Average Payables Full definition →		3,878.50	3,588.50	4,118.00	4,792.50
Average Inventory Full definition →		3,045.00	2,623.50	2,711.00	2,737.00
Average Assets Full definition →		95,279.50	91,320.50	89,451.50	91,155.00
Average Common Equity Full definition →		17,899.50	17,446.50	18,774.50	19,904.00

Fold the line items

Columns are period end dates

Stockrow Weekly